Partneringdesk Deals and Alliances In Respiratory Diseases

Countries covered: United States Partneringdesk deals and alliances in respiratory diseases provides an in-depth view of 500 deals and alliances announced in respiratory diseases between 2001 and 2006, in a clear and accessible PDF format. Reasons to purchase (USPs and key questions answered) Partneringdesk Deals and alliances in respiratory diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in: the assessment of deal-making trends in the last five years identifying active partners tracking competitor activity benchmarking deals Partneringdesk deals and alliances in respiratory diseases brings all the relevant partnering deals into one place, providing a ready reference to deal making in respiratory diseases. Report scope The report contains: fully categorized deal overviews financial information where disclosed company profiles of the top 25 dealmakers in the report specialized indexes by company, development stage, deal type and industry sector. wider coverage of Japanese deals courtesy of JCN Forecasts, projections, market estimates This report provides a series of charts with analyses detailing market trends in respiratory diseases deal making over the period of 2001 to 2006. Methodology This report is derived from data obtained from Pharmalicensing’s Partneringdesk deals and alliances database. The database is updated daily using industry sources.

Additional Information

Who should buy the report This report is essential reading for board and executive management, and individuals in:

• business development
• licensing/partnering
• deal making
• business strategy
• marketing and promotion
• distribution and manufacturing (including contract services).

Companies analyzed/mentioned
3M
AeroGen
AstraZeneca
Battelle Pulmonary Therapeutics
Baxter Healthcare
Bespak plc
Boehringer Ingelheim GmbH
Chiesi Farmaceutici SpA
Cystic Fibrosis Foundation Therapeutics
Eiffel Technologies
GlaxoSmithKline
Global Alliance for Tuberculosis Drug Development
Hemispherx BioPharma Inc
Innovata Biomed
InterMune
Inyx Inc
IVAX Corporation
National Institute of Allergy and Infectious Diseases
Novartis AG
Pfizer Inc
Profile Therapeutics plc
QRS Diagnostic
SkyePharma
Tm Bioscience
US Army Medical Research Institute of Infectious Diseases

More United States Respiratory/Pulmonary Reports

Epidemiology: COPD - Aging population and stable smoking rates to raise case numbers by Datamonitor
Introduction In 2010, Datamonitor estimates that there were about 69.5 million total prevalent cases of chronic obstructive pulmonary disease (COPD) in people aged over 40 in ...

Cystic Fibrosis by Global Industry Analysts
This report analyzes the US market for Cystic Fibrosis in Millions of US$. Annual estimates and forecasts are provided for the period of 2007 through ...

U.S. Sleep Apnea Diagnostic and Therapeutic Devices Markets by Frost & Sullivan
This research service analyzes market trends in the U.S. sleep apnea diagnostic and therapeutic devices market since 2005, predicts future changes in market measurements through ...

Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections) by Kalorama Information
A nosocomial, or hospital-acquired, infection is a new infection that is usually defined as an infection that is identified at least forty-eight to seventy-two hours ...

The U.S. Sleep Market by Marketdata Enterprises Inc.
Of a total population of 305 million Americans, 58% are estimated to experience insomnia symptoms or sleep disorders. Companies across America are trying to sell ...

See all reports like this >>

More United States Reports

e-Discovery Software Publishing in the US - Industry Market Research Report by IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...

D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report United States January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Coal - US - a snapshot (2010) by Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...

See all reports like this >>